4.5 Review

miRNA as biomarker in lung cancer

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Long non-coding RNAs: an overview on miRNA sponging and its co-regulation in lung cancer

Santhosh Rajakumar et al.

Summary: Research has found that non-coding RNAs play a crucial role in the development and progression of lung cancer and can serve as potential biomarkers for early detection and treatment. Among them, lncRNAs and miRNAs are the most studied non-coding RNAs, influencing lung cancer development by negatively regulating the expression of target genes and competing with each other in the translational inhibition process.

MOLECULAR BIOLOGY REPORTS (2023)

Review Oncology

Next generation sequencing for liquid biopsy based testing in non-small cell lung cancer in 2021

Pasquale Pisapia et al.

Summary: Lung cancer is the leading cause of cancer death worldwide, with liquid biopsy technology showing promising applications in NSCLC patients. Molecular profiling of liquid biopsy specimens using next generation sequencing technologies is rapidly evolving.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

Article Biochemistry & Molecular Biology

Genetic Markers in Lung Cancer Diagnosis: A Review

Katarzyna Wadowska et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance

Mohammad Askandar Iqbal et al.

MOLECULAR ASPECTS OF MEDICINE (2019)

Review Medicine, General & Internal

Are There New Biomarkers in Tissue and Liquid Biopsies for the Early Detection of Non-Small Cell Lung Cancer?

Fiorella Calabrese et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Review Respiratory System

Liquid biopsy for early stage lung cancer

Wenhua Liang et al.

JOURNAL OF THORACIC DISEASE (2018)

Review Biochemistry & Molecular Biology

Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy

Jose Marrugo-Ramirez et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Pharmacology & Pharmacy

MiRNA-based Therapeutics for Lung Cancer

Miaowei Wu et al.

CURRENT PHARMACEUTICAL DESIGN (2017)

Review Pharmacology & Pharmacy

Role of miRNA in Lung Cancer-Potential Biomarkers and Therapies

Xiaohong Du et al.

CURRENT PHARMACEUTICAL DESIGN (2017)

Article Medicine, Research & Experimental

miR-135b reverses chemoresistance of non-small cell lung cancer cells by downregulation of FZD1

Wenmei Su et al.

BIOMEDICINE & PHARMACOTHERAPY (2016)

Article Oncology

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers

Lei Yu et al.

INTERNATIONAL JOURNAL OF CANCER (2010)